Search

One of the research interests in our lab is focused on the deep-molecular characterization of a clinically well-defined cohort of patients anchored in genomic data. Alzheimer’s (AD) and Parkinson’s disease (PD) are heterogeneous disorders with identifiable clinical-pathological subtypes based on...

Benitez Lab current collaborators include: David Simon, Sam Frank, Lan Luo, Feng Tian, Daniel Press, Stephanie Buss, Subhash Kulkarni, P.A.I.N.T, and the Movement Disorders Center.

Panel-based Genetic Diagnostic Testing for Inherited Eye Diseases is Highly Accurate and More Sensitive than Exome Sequencing Departmental investigators and colleagues in the HMS Ophthalmology Ocular Genomics Institute (OGI) recently reported the development and characterization of a comprehensive...

How biomedical breakthroughs in anti-VEGF research have changed how we diagnose, treat, and save vision for patients with retinal disease. Annually, 500,000 ophthalmic patients in the United States and over 1 million worldwide are treated with all anti-VEGF agents combined. Anti-VEGF treatments have...

The National Institutes of Health (NINDS, NIA) provides funding for projects in our lab. We are also sincerely grateful to the patients, family members, and caregivers who donated their time, brains, and biospecimens for biomedical research. __________________________________________________________...